Under my scenario, there is no Saliva test ready for market. My scenario, and I'm just throwing this out there as my opinion, is:
1. Charter figured out in 2003 that DR-70 would work with saliva.
2. The 6,600 participants claim is suspicious and the lack of clinical trial data is suspicious - I doubt these clinical trials were legitimate. I think this is all marketing hype and half-truths. Trial data would prove me wrong. Where is the trial data?
3. Charter doesn't want to manufacture the spit test, he wants to sell the idea to someone. To accomplish this he had his website-making buddy make a shiny website and he got the DR-70 manufacturing procedures and equipment from Radient.
I don't think GCDx "figured it out" because they seem to have failed to get financing at every turn. I think GCDx is desperately playing their last hand and will probably disappear by this time next year because they are under-funded.
GCDx stooped to crowdsourcing twice and failed each time (the second attempt ends in about 30 hours). That is not the sign of a well-funded "good idea." That is the sign of a bad idea that can't get funding.
GCDx also has not published their "Validation Study." Anyone who would pay for a test just because the seller SAYS "it works!" is a fool in my opinion. Also, I think the FDA is going to shut down GCDx if they don't shut it down themselves. The FDA moves slow but GCDx is not playing by the FDA's rules IMO.
As for debt collectors... agreed, they won't go off-continent.